Lorne J. Hofseth
Lorne J. Hofseth was born in Vancouver, Canada, in 1967. He received his Ph.D. degree from Simon Fraser University, Canada, in 1996. His dissertation focus was on inflammation and cancer. From 1996 to 1999, he pursued his first postdoctoral study at Michigan State University, studying the impact of hormones on breast cancer. In 2000, he moved to Bethesda, Maryland, to pursue another postdoctoral study at the National Cancer Institute. There, he continued his focus on inflammation and cancer, primarily concentrating on colitis and colon cancer. In 2004, he moved to the University of South Carolina, where he serves now as a Tenured Associate Professor in the South Carolina College of Pharmacy. Currently, his research interests revolve around chronic inflammation and cancer. Chronic inflammation is dangerous to human health. It drives many prevalent diseases in our society, including heart disease, diabetes, Alzheimer's, and cancer. Current treatment strategies to dampen signs and symptoms of chronic inflammation are limited, and fraught with side-effects. Dr. Hofseth has dedicated his career to identifying novel targets and therapeutic approaches to suppressing inflammation, with minimal toxicity. One way is through the use of common complementary and alternative medicines that have anti-inflammatory properties. Another way is to team up with biochemists who synthesize small molecule inhibitors of specific pro-inflammatory molecules. Dr. Hofseth also carries out clinical trials to examine the role of anti-oxidants in suppressing systemic inflammation, and improve overall health. Our bench-to-bedside approach will have far-reaching health implications on millions of people suffering from auto-immune and chronic inflammatory diseases. Dr. Hofseth has published over 60 times in peer-reviewed journals.
Biography Updated on 22 January 2012